Bioxyne Limited (ASX:BXN)

Market Cap	170.29M +202.6%
Revenue (ttm)	47.95M +178.2%
Net Income	8.97M +300.8%
EPS	0.00 +259.9%
Shares Out	2.27B
PE Ratio	18.90
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,850,786
Open	0.0810
Previous Close	0.0810
Day's Range	0.0740 - 0.0810
52-Week Range	0.0240 - 0.0920
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 25, 2026

About Bioxyne

Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan. It operates through Pharmaceutical Manufacture and Wholesale Supply of Novel Medicines, Cannabis, Psilocybin, and MDMA; Manufacture and Distribution (Wholesale, Online, and Retail) of Consumer Health and Novel Food Products; and Wholesale of Patented Probiotics segments. The company offers active pharmaceutical ingr...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1998
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: BXN